T. pallidum, ROS, and Hepatocyte Apoptosis

Liver involvement is recognized during syphilis, yet the cellular events connecting Treponema pallidum exposure with hepatocyte injury remain incompletely defined. The reference study, published in Microbial Pathogenesis, examines whether the mitochondrial, or intrinsic, apoptosis pathway contributes to this injury and places mitochondrial reactive oxygen species within a proposed mechanistic sequence. The study is available through the reference paper.

Study Background and Research Question

T. pallidum is a systemic spirochete capable of producing diverse clinical manifestations. Although hepatic involvement can occur during syphilis and bacterial DNA has been detected in hepatic tissue, the organism is not generally considered hepatotropic. This distinction makes it important to separate direct cellular effects from broader inflammatory or systemic processes.

Hepatocytes have high metabolic activity and contain abundant mitochondria. They are therefore especially vulnerable to disturbances in mitochondrial membrane potential, electron transport, redox balance, and ATP production. The investigators focused on intrinsic apoptosis because this pathway responds to intracellular stress through mitochondrial permeabilization and release of pro-apoptotic factors. Their central question was whether T. pallidum induces hepatocyte apoptosis by impairing mitochondrial function, increasing ROS, and promoting oxidation of cardiolipin, a mitochondria-enriched phospholipid.

Key Innovation from the Reference Study

The main innovation is the positioning of mitochondrial ROS accumulation as an upstream organizer of several connected injury phenotypes rather than as an isolated marker of oxidative stress. The study links bacterial exposure to mitochondrial dysfunction, oxidized cardiolipin, cytochrome c-associated apoptotic signaling, and executioner caspase activation. This is more informative than measuring apoptosis alone because it provides a biologically coherent sequence from organelle stress to cell death.

Cardiolipin is concentrated in the inner mitochondrial membrane and contributes to membrane organization and respiratory function. Its peroxidation can destabilize mitochondrial architecture and favor the release of apoptogenic factors. In the reference model, cardiolipin oxidation was evaluated alongside mitochondrial membrane potential, mitochondrial permeability transition pore opening, ROS, and ATP. The use of a targeted ROS inhibitor supplied an intervention-based test of the proposed pathway. Reversal of several downstream phenotypes after ROS inhibition supports a mechanistic role for oxidative stress, although it does not establish that every step is exclusively dependent on ROS.

Methods and Experimental Design Insights

The investigators used THLE-2 hepatocytes as an in vitro liver-cell model and exposed them to the Nichols strain of T. pallidum. The strain was propagated in adult male New Zealand rabbits and harvested using previously described procedures. The work was conducted under institutional ethical approval from Zhongshan Hospital of Xiamen University. This design enabled controlled comparison of bacterial exposure, apoptosis, mitochondrial function, and oxidative damage in the same cellular system.

The experimental readout panel was appropriately multidimensional. Apoptosis was assessed together with the Bax/Bcl-2 balance, cytochrome c, Caspase-9, Caspase-3, and cleaved Caspase-3. Mitochondrial status was examined through membrane-potential loss, mitochondrial permeability transition pore opening, ATP reduction, ROS accumulation, and oxidized cardiolipin. A ROS-inhibition condition was then used to determine whether suppressing oxidative stress could mitigate the mitochondrial and apoptotic responses.

Protocol Parameters

• Cell model: THLE-2 hepatocytes were used to model hepatocyte responses to T. pallidum; results should not be assumed to represent primary human hepatocytes without validation.
• Bacterial material: The study used the Nichols strain, propagated in adult male New Zealand rabbits before harvesting; strain and preparation can influence reproducibility.
• Exposure design: The investigators compared bacterial treatment across a dose range and evaluated dose-responsive apoptosis and mitochondrial changes. Exact inoculum and exposure parameters should be taken from the full methods before replication.
• Apoptosis controls: The supplied study text identifies a 24-hour apoptosis-positive-control condition. Control timing should be matched carefully with the treatment schedule.
• Mechanistic perturbation: A targeted ROS inhibitor was included to test whether oxidative stress was functionally upstream of mitochondrial damage, cardiolipin oxidation, and apoptosis.
• Readout strategy: ATP should be interpreted as a functional bioenergetic endpoint alongside membrane potential, permeability transition, ROS, cardiolipin oxidation, and caspase signaling rather than as a standalone apoptosis marker.

Core Findings and Why They Matter

Apoptosis increased with bacterial exposure. In THLE-2 cells, T. pallidum treatment produced a dose-dependent increase in apoptosis. This was accompanied by a higher Bax/Bcl-2 ratio and increased cytochrome c, Caspase-9, Caspase-3, and cleaved Caspase-3. The pattern is consistent with activation of the mitochondrial intrinsic pathway rather than an exclusively receptor-mediated death response. The reported statistical associations, including P values ranging from less than 0.05 to less than 0.001 for several apoptotic markers, are described in the reference study.

Mitochondrial function deteriorated in parallel. Treated cells showed loss of mitochondrial membrane potential, increased mitochondrial permeability transition pore opening, ROS accumulation, and reduced ATP levels. The ATP result is important because it connects structural and redox damage with impaired cellular energy availability. However, ATP depletion is not exclusively mitochondrial: it can also reflect altered substrate use, reduced glycolytic compensation, reduced cell number, or changes in ATP consumption. It is therefore strongest when interpreted as part of the study's integrated mitochondrial profile.

Cardiolipin peroxidation emerged as a key downstream event. Oxidized cardiolipin increased after T. pallidum treatment. Because cardiolipin is closely associated with mitochondrial membrane integrity and cytochrome c organization, this finding offers a plausible molecular bridge between ROS accumulation and apoptotic signaling. The study therefore advances a model in which bacterial exposure disrupts mitochondria, elevates ROS, promotes cardiolipin peroxidation, and facilitates intrinsic apoptosis.

ROS inhibition provided causal support. Targeted inhibition of ROS reduced mitochondrial injury, cardiolipin peroxidation, and apoptotic responses. This rescue experiment strengthens the interpretation that ROS is not merely a consequence of dying cells. Nevertheless, pharmacological inhibitors can have off-target effects, and a stronger causal framework would include complementary genetic or chemically distinct ROS interventions. The authors' results support ROS as an important upstream mediator, not necessarily the only mediator.

Comparison with Existing Internal Articles

An internal resource on ATP workflows in ulcerative-colitis models also frames ATP depletion as a measurable feature of cellular stress and mitochondrial injury. Its disease context differs from syphilitic hepatocyte injury, but the methodological relationship is useful: both settings benefit from pairing ATP measurements with oxidative and organelle-level endpoints rather than treating luminescence as a complete mechanistic explanation.

A separate internal article on PXDN, LDHA, and glycolysis in glioblastoma approaches metabolism through glycolytic regulation and disease-associated cell behavior. In contrast, the reference study emphasizes mitochondrial membrane damage, ROS, and cardiolipin oxidation. Together, these resources illustrate that ATP or metabolic changes can arise from distinct biological processes; comparable ATP values should not be interpreted as evidence for the same mechanism.

Why this cross-domain matters, maturity, and limitations

Comparing hepatocyte infection models with inflammatory or cancer metabolism studies is useful for assay planning, but it is a conceptual bridge rather than evidence that the same pathway operates identically across diseases. The reference findings are most mature at the level of the THLE-2 cell model and the tested bacterial strain. Applying the workflow to primary hepatocytes, organoids, liver tissue, or other disease systems requires independent validation of exposure, cell composition, bacterial burden, and compensatory metabolism.

Limitations and Transferability

The principal limitation is the in vitro experimental system. THLE-2 cells do not reproduce the multicellular environment of the liver, including Kupffer cells, endothelial cells, stellate cells, circulating immune mediators, and tissue oxygen gradients. A controlled bacterial exposure also differs from natural infection, where bacterial dissemination, host immunity, and antimicrobial treatment may shape hepatocyte stress.

The study uses one T. pallidum strain and therefore does not establish whether the observed effects are strain-general. The condensed report also does not provide all exposure concentrations, bacterial-to-cell ratios, or assay-specific normalization details. These parameters are essential for comparing results across laboratories. ATP reduction should additionally be normalized with care, because fewer viable cells can lower total ATP independently of a per-cell mitochondrial defect.

Mechanistically, ROS inhibition is a valuable rescue experiment, but it does not by itself prove that cardiolipin peroxidation is indispensable. Future validation would benefit from orthogonal measurements of mitochondrial lipid oxidation, direct assessment of cytochrome c redistribution, and confirmation in primary or three-dimensional hepatic models. In vivo studies would also be needed to determine whether the cellular pathway contributes materially to liver abnormalities during syphilis.

Despite these limitations, the study provides a useful experimental framework. It demonstrates how cellular ATP quantification can be integrated with mitochondrial potential, permeability transition, ROS, cardiolipin, and caspase measurements to distinguish general cytotoxicity from a more specific intrinsic-apoptosis phenotype.

Research Support Resources

For related cellular ATP quantification, an Luminescent ATP Detection Assay Kit (SKU K2040) can support intracellular ATP level detection in cell lysates and ATP measurement in tissue samples. It uses a firefly luciferase ATP assay, with a ready-to-use lysis workflow and a reported linear range of 1 nM to 10 μM ATP; the product information also reports a luminescent signal stable for up to 30 minutes. These features may be useful when ATP is included as one component of an energy metabolism assay, provided that luminescence is normalized and interpreted alongside the mitochondrial and apoptotic endpoints described in the reference study.